小滴
2021-07-21
[微笑]
@牛唐：
市值低于现金的企业，是机会吗
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":178477602,"tweetId":"178477602","gmtCreate":1626834803306,"gmtModify":1626834803306,"author":{"id":3573102416837786,"idStr":"3573102416837786","authorId":3573102416837786,"authorIdStr":"3573102416837786","name":"小滴","avatar":"https://static.tigerbbs.com/db4a32287ea6634d9257724dc05b64f0","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n[微笑]</body></html>","htmlText":"<html><head></head><body>\n[微笑]</body></html>","text":"[微笑]","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/178477602","repostId":170308958,"repostType":1,"repost":{"magic":2,"id":170308958,"tweetId":"170308958","gmtCreate":1626402275174,"gmtModify":1626402275174,"author":{"id":3452938437060827,"idStr":"3452938437060827","authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6323,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"市值低于现金的企业，是机会吗","extraTitle":"","html":"<html><head></head><body><p><a target=\"_blank\" href=\"https://laohu8.com/S/GLPG\">$Galapagos NV(GLPG)$</a> 市值37亿美元，账上有近50亿欧元。</p><p>股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据：</p><p>治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。</p><p><a target=\"_blank\" href=\"https://laohu8.com/S/03692\">$翰森制药(03692)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/IMAB\">$天境生物(IMAB)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/ADAG\">$天演药业(ADAG)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/CNTB\">$康乃德生物医药(CNTB)$</a> </p></body></html>","htmlText":"<html><head></head><body><p><a target=\"_blank\" href=\"https://laohu8.com/S/GLPG\">$Galapagos NV(GLPG)$</a> 市值37亿美元，账上有近50亿欧元。</p><p>股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据：</p><p>治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。</p><p><a target=\"_blank\" href=\"https://laohu8.com/S/03692\">$翰森制药(03692)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/IMAB\">$天境生物(IMAB)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/ADAG\">$天演药业(ADAG)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/CNTB\">$康乃德生物医药(CNTB)$</a> </p></body></html>","text":"$Galapagos NV(GLPG)$ 市值37亿美元，账上有近50亿欧元。 股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据： 治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。 $翰森制药(03692)$ $天境生物(IMAB)$ $天演药业(ADAG)$ $康乃德生物医药(CNTB)$","highlighted":1,"essential":1,"paper":2,"link":"https://laohu8.com/post/170308958","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["GLPG","ADAG","IMAB","03692","CNTB"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":352,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":2329,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/178477602"}
精彩评论